title: Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.
abstract: Overexpression of epidermal growth factor receptor (EGFR) is associated with resistance to chemotherapy and radiotherapy, advanced tumor stage, invasion, metastasis and poor prognosis in malignant tumors. EGFR, therefore, has been an attractive molecular target for chemotherapy. However, the results of clinical studies using inhibitors of its kinase activity have not been promising because the response rates were at most 20%. Sodium-glucose co-transporter 1 (SGLT1) is a membrane protein that mediates the transport of glucose across cellular membranes. EGFR physically associates with and stabilizes SGLT1 to promote glucose uptake into cancer cells through a kinase-independent process. The purpose of this study was to investigate the coexpression of SGLT1 and EGFR and its relationships with clinicopathological features in oral squamous cell carcinoma (OSCC). SGLT1 and EGFR were detected in all OSCC cell lines, and the expression levels of SGLT1 were significantly correlated with those of EGFR. Pearson product-moment correlation coefficient of SGLT1 and EGFR was 0.89 (P = 0.016). The immunohistochemical study using the surgical specimens in 52 patients with tongue SCC also showed a significant correlation between SGLT1 and EGFR. Moreover, SGLT1/EGFR expression was inversely related to tumor differentiation among the 5 clinicopathological factors (P = 0.004). SGLT1/EGFR coexpression might be required in the de-differentiation of OSCC, but further study is needed to clarify the implication of these proteins in the manifestation of malignancy and clinical significance.
authors: Department of Oral and Maxillofacial Surgery, Oral Restitution, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
authors: Yasuko
authors: Y
authors: Hanabata
authors: Yusuke
authors: Y
authors: Nakajima
authors: Kei-ichi
authors: K
authors: Morita
authors: Kou
authors: K
authors: Kayamori
authors: Ken
authors: K
authors: Omura
references: Cancer Cell. 2008 May;13(5):375-6
references: 18455118
references: Cell. 1993 May 21;73(4):713-24
references: 8500165
references: Pharmacol Ther. 2009 Jan;121(1):29-40
references: 18992769
references: Dig Dis Sci. 2003 Aug;48(8):1614-8
references: 12924656
references: Oral Oncol. 2009 Apr-May;45(4-5):324-34
references: 18805044
references: Cancer Cell. 2008 May;13(5):385-93
references: 18455122
references: J Oral Pathol Med. 2010 Aug 1;39(7):525-32
references: 20040024
references: Cancer. 1983 Jun 15;51(12):2175-80
references: 6189571
references: Oral Oncol. 2003 Apr;39(3):222-31
references: 12618194
references: Cancer Lett. 2000 Dec 8;161(1):9-15
references: 11078908
references: Cancer Cell. 2005 Jun;7(6):575-89
references: 15950906
references: Nat Cell Biol. 2006 Dec;8(12):1359-68
references: 17115032
references: Oral Oncol. 2007 Feb;43(2):193-8
references: 16854613
references: Clin Cancer Res. 2006 Sep 15;12(18):5268-72
references: 17000658
references: Clin Cancer Res. 2002 Mar;8(3):885-92
references: 11895923
references: Oral Oncol. 2004 Jan;40(1):28-35
references: 14662412
references: Lancet. 2003 Jul 5;362(9377):62-4
references: 12853203
references: Oral Oncol. 2008 Mar;44(3):227-35
references: 17604679
references: Cancer Lett. 2003 Nov 25;201(2):149-55
references: 14607328
references: Nat Rev Cancer. 2004 May;4(5):361-70
references: 15122207
references: Oral Oncol. 2008 Mar;44(3):270-6
references: 17468034
references: Nat Rev Cancer. 2004 Nov;4(11):891-9
references: 15516961
references: Nat Rev Mol Cell Biol. 2001 Feb;2(2):127-37
references: 11252954
references: Br J Cancer. 2009 Apr 7;100(7):1087-94
references: 19293803
references: Cancer Res. 2002 Dec 15;62(24):7350-6
references: 12499279
references: Cancer Res. 2009 Mar 15;69(6):2568-76
references: 19276369
references: Head Neck Surg. 1984 May-Jun;6(5):938-47
references: 6724960